Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M25,439Revenue (TTM) $M10,121Net Margin (%)48.7Altman Z-Score5.4
Enterprise Value $M25,669EPS (TTM) $8.9Operating Margin %6.1Piotroski F-Score5
P/E(ttm)5.2Beneish M-Score-2.5Pre-tax Margin (%)48.2Higher ROA y-yY
Price/Book2.910-y EBITDA Growth Rate %-4.0Quick Ratio1.9Cash flow > EarningsN
Price/Sales2.65-y EBITDA Growth Rate %-17.7Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow33.5y-y EBITDA Growth Rate %350ROA % (ttm)27.3Higher Current Ratio y-yY
Dividend Yield %1.1PEG--ROE % (ttm)57.5Less Shares Outstanding y-yN
Payout Ratio %6.0Shares Outstanding M544ROIC % (ttm)7.0Gross Margin Increase y-yN

Gurus Latest Trades with BAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAXLeucadia National 2016-09-30 Sold Out -3.67%$45.09 - $49.03
($47.16)
$ 46.77-1%Sold Out0
BAXRichard Pzena 2016-09-30 Reduce-0.58%$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -65.93%1,061,577
BAXTweedy Browne 2016-09-30 Reduce-0.3%$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -9.87%2,157,391
BAXVanguard Health Care Fund 2016-09-30 Reduce-0.21%$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -30.49%4,902,940
BAXJoel Greenblatt 2016-09-30 Reduce-0.11%$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -24.86%638,063
BAXFirst Eagle Investment 2016-09-30 Add0.06%$45.09 - $49.03
($47.16)
$ 46.77-1%Add 23.75%2,635,577
BAXCharles Brandes 2016-09-30 Sold Out -0.05%$45.09 - $49.03
($47.16)
$ 46.77-1%Sold Out0
BAXGeorge Soros 2016-09-30 Reduce-0.04%$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -10.55%254,327
BAXKeeley Asset Management Corp 2016-09-30 Reduce$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -2.05%57,410
BAXMario Gabelli 2016-09-30 Reduce$45.09 - $49.03
($47.16)
$ 46.77-1%Reduce -1.28%123,500
BAXLeucadia National 2016-06-30 Buy 3.67%$41.08 - $46.39
($43.82)
$ 46.777%New holding700,000
BAXDavid Einhorn 2016-06-30 Sold Out -0.84%$41.08 - $46.39
($43.82)
$ 46.777%Sold Out0
BAXJoel Greenblatt 2016-06-30 Reduce-0.39%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -49.91%849,128
BAXVanguard Health Care Fund 2016-06-30 Reduce-0.37%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -36.89%7,053,480
BAXFirst Eagle Investment 2016-06-30 Add0.25%$41.08 - $46.39
($43.82)
$ 46.777%Add 193512.09%2,129,733
BAXRichard Pzena 2016-06-30 Reduce-0.24%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -23.71%3,115,865
BAXGeorge Soros 2016-06-30 Reduce-0.19%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -36.56%284,327
BAXCharles Brandes 2016-06-30 Reduce-0.14%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -75.67%75,584
BAXTweedy Browne 2016-06-30 Reduce-0.11%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -3.97%2,393,665
BAXMario Gabelli 2016-06-30 Reduce-0.01%$41.08 - $46.39
($43.82)
$ 46.777%Reduce -18.63%125,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STORM KORNELIS J.Director 2016-11-18Sell4,280$47.1-0.98view
ALMEIDA JOSE EChairman of the Board and CEO 2016-05-23Buy11,691$42.759.1view
FORSYTH JOHN DDirector 2016-05-02Sell1,887$44.385.09view
FORSYTH JOHN DDirector 2016-04-04Sell1,887$41.7511.71view
STROUCKEN ALBERT P LDirector 2016-03-14Sell5,660$40.3315.65view
GAVIN JAMES R IIIDirector 2016-03-14Sell5,660$40.3415.62view
FORSYTH JOHN DDirector 2016-03-14Sell1,886$40.315.73view
HELLMAN PETER SDirector 2016-02-17Sell5,660$38.3521.62view
STORM KORNELIS J.Director 2016-02-11Sell5,660$35.9829.63view
Shapazian Carole JDirector 2015-05-22Sell1,533$67.68-31.09view

Quarterly/Annual Reports about BAX:

News about BAX:

Articles On GuruFocus.com
Steven Romick Spots Next Area of Interest, Health Care Jan 13 2017 
Bill Nygren Comments on Baxter Jan 10 2017 
10 Stocks Trading Below Their Graham Number Dec 19 2016 
10 Undervalued Stocks for the Defensive Investor Dec 15 2016 
10 Stocks for Using a Benjamin Graham Value Investing Strategy Dec 09 2016 
10 Low PE Stocks for the Defensive Investor Dec 08 2016 
9 Stocks First Eagle Keeps Buying Nov 10 2016 
Vanguard Health Care Fund Sells Amgen, Baxter Nov 02 2016 
Medical Companies Offer Good Value Opportunities Sep 16 2016 
10 Undervalued Stocks for the Defensive Investor Sep 13 2016 

More From Other Websites
Spectrum Health Recognized for Excellence in Community Service with 2016 Foster G. McGaw Prize Jan 18 2017
Baxter (BAX): Sluggish Macro Environment Mars Prospects Jan 18 2017
Baxter to pay $18 mln over mold at North Carolina plant Jan 12 2017
Baxter Healthcare to pay $18 mln to resolve liability -U.S. Jan 12 2017
Baxter International, Inc. – Value Analysis (NYSE:BAX) : January 11, 2017 Jan 11 2017
Blog Coverage Teleflex's Arrow(R) VPS Rhythm(TM) Device gets FDA Clearance; Launches Laryngeal Mask Jan 11 2017
Bill Nygren's Oakmark Fund Commentary: Fourth Quarter 2016 Jan 10 2017
Baxter International, Inc. breached its 50 day moving average in a Bullish Manner : BAX-US : January... Jan 10 2017
New Data Show U.S. Hospital Readmissions are 54 Percent Higher for Malnourished Patients Jan 09 2017
Baxter International Inc. to Host Fourth Quarter 2016 Financial Results Conference Call for... Jan 06 2017
Baxter International Inc. to Host Fourth Quarter 2016 Financial Results Conference Call for... Jan 06 2017
Is Baxter Poised to Counter Low Cyclophosphamide Sales? Dec 30 2016
Boston Scientific Down on Risks; Innovations Raise Hope Dec 27 2016
Financial Metrics of Baxter’s Acquisition of Claris Injectables Dec 26 2016
How Baxter’s Acquisition of Claris Injectables Could Boost Growth Dec 23 2016
Baxter Advances Portfolio with Acquisition of Claris Injectables Dec 23 2016
What Do Analysts Recommend for Baxter International? Dec 23 2016
Myriad Genetics: United Rheumatology Selects Vectra DA Test Dec 23 2016
VWR Plagued by Headwinds, Solid Fundamentals Raise Hope Dec 21 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)